Sruti Murali

Dr. Sruti Murali

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2021 in Odovtos - International Journal of Dental Sciences
Verified
Journal Article
Open access
PDF file
MSManu Sharma
Manu Sharma
AFArishiya Thapasum Fairozekhan
Arishiya Thapasum Fairozekhan
FMFaraz Mohammed
Faraz Mohammed
SJS.R. Janani
S.R. Janani
SMSruti Murali
Sruti Murali
KSKarthik Shunmugavelu
Karthik Shunmugavelu
Vitiligo is an acquired hypomelanotic disorder of the skin resulting from loss of functional melanoctyes and it affects approximately 0.5-1% of individuals. 25% of vitiligo in children are diagnosed before 10 years of age. The age of onset of vitiligo in children ranges between 4 to 8 years. Depigmentation in oral cavity can be easily noted and awareness about the condition can be created if they are not aware about vitiligo elsewhere in their body and can be guided for the treatment.

17 October 2026 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
UMUjjawal Mishra
Ujjawal Mishra
MRManu Rajput
Manu Rajput
VGVivek Gupta
Vivek Gupta
SMSruti Murali
Sruti Murali
AGAngshuman Borpatra Gohain
Angshuman Borpatra Gohain
Sujita Kumar KarSujita Kumar Kar
Sujita Kumar Kar

26 September 2024
Verified
Journal Article
Open access
PDF file
VMVasanth Mn
Vasanth Mn
SMSruti Murali
Sruti Murali
PBPalak Borade
Palak Borade
PBPriyanka Bhangale
Priyanka Bhangale
LPLakshmi V Pillai
Lakshmi V Pillai
SUSudharani
Sudharani
Apexification aims to induce apical closure in immature, non-vital teeth with open apices, facilitating periapical healing and root development. Traditional methods, while effective, can be time-consuming and unpredictable. This case series evaluates the use of recombinant human platelet-derived growth factor (rhPDGF) combined with beta tricalcium phosphate (β-TCP) as a novel apical barrier in apexification procedures. A 9-month follow-up was conducted to assess clinical outcomes and periapical healing. two patients presenting with immature non-vital teeth and open apices were treated using rhPDGF and β-TCP as an apical barrier and MTA was all so placed. After thorough debridement and disinfection of the root canal system, a mixture of rhPDGF and β-TCP was placed at the apical region to stimulate bone formation and induce apical closure followed by mta was placed. Radiographs were taken pre-operatively, immediately post-operatively, and at 9 months to evaluate apical barrier formation and periapical healing.All treated cases demonstrated favorable clinical and radiographic outcomes at the 9-month follow-up. Radiographs revealed substantial apical bone regeneration with clear evidence of apical closure. No patients exhibited signs of infection, pain, or complications during the follow-up period. The use of rhPDGF and β-TCP consistently promoted the formation of a functional apical barrier and periapical tissue healing, providing a biologically favorable environment for root-end closure.

27 October 2026 in The Open Biomarkers Journal
Verified
Journal Article
Open access
PDF file
SMSruti Murali
Sruti Murali
RPRevinselvan Prakash
Revinselvan Prakash
SRSivaramakrishnan Ramachandiran
Sivaramakrishnan Ramachandiran
SRSuresh Lakki Reddy
Suresh Lakki Reddy
Introduction: Identification of non-invasive biomarkers reflecting glycaemic status and microvascular risk remains a priority in type 2 Diabetes Mellitus (T2DM). α 2 -Macroglobulin (α 2 MG), a high-molecular-weight acute-phase glycoprotein involved in inflammatory regulation, increases in hyperglycaemic states and may be detectable in saliva. This study evaluated the association of salivary α 2 MG with glycaemic control and Diabetic Retinopathy (DR). Methods: In this cross-sectional study (January–October 2025), 130 adults were categorised as healthy controls (n=26), controlled T2DM (n=52), and uncontrolled T2DM (n=52). Unstimulated saliva was collected and α 2 MG quantified by enzyme-linked immunosorbent assay. Glycaemic indices, lipid parameters, insulin levels, Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), and DR status were assessed. Correlation, multivariable regression, and Receiver Operating Characteristic (ROC) analyses were performed. Results: Salivary α 2 MG concentrations were significantly higher in uncontrolled T2DM than in controlled T2DM and controls ( P < 0.001). α 2 MG correlated positively with fasting glucose, postprandial glucose, glycated haemoglobin (HbA1c), triglycerides, insulin levels, and HOMA-IR. Participants with DR had significantly higher α 2 MG concentrations than those without retinopathy ( P < 0.001). ROC analysis showed modest discrimination for identifying uncontrolled T2DM, with an optimal cut-off of 764 ng/mL (sensitivity 76.15%; specificity 70%). Discussion: These findings suggest salivary α 2 MG reflects both metabolic dysregulation and microvascular injury, supporting its potential relevance as a non-invasive adjunct biomarker in diabetes monitoring, complication risk assessment, and microvascular risk stratification in T2DM. Conclusion: Salivary α 2 MG was associated with glycaemic dysregulation and DR in T2DM, supporting its potential as a non-invasive adjunct biomarker. Its ease of collection may facilitate metabolic assessment, particularly in resource-limited settings, pending longitudinal validation.

24 September 2026 in Evidence-Based Dentistry
Verified
Journal Article
Closed access
PDF file
SMSruti Murali
Sruti Murali
SMSruti Murali
Sruti Murali